Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

A Study of Risperidone Monotherapy in Bipolar Anxiety

This study has been completed.
Sponsor:
Collaborator:
Janssen, LP
Information provided by:
University of South Florida
ClinicalTrials.gov Identifier:
NCT00167479
First received: September 10, 2005
Last updated: September 8, 2006
Last verified: September 2006
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: September 2006
  Estimated Primary Completion Date: No date given